We are live on ! Find out more
TECH icon

Bio-Techne

356 hedge funds and large institutions have $7.07B invested in Bio-Techne in 2019 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 128 increasing their positions, 109 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 24

37% more capital invested

Capital invested by funds: $5.16B → $7.07B (+$1.91B)

17% more repeat investments, than reductions

Existing positions increased: 128 | Existing positions reduced: 109

9% more funds holding

Funds holding: 328356 (+28)

0.44% more ownership

Funds ownership: 376.56%377% (+0.44%)

34% less call options, than puts

Call options by funds: $2.94M | Put options by funds: $4.47M

Holders
356
Holders Change
+28
Holders Change %
+8.54%
% of All Funds
7.68%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
56
Increased
128
Reduced
109
Closed
24
Calls
$2.94M
Puts
$4.47M
Net Calls
-$1.53M
Net Calls Change
-$2.27M

TECH Hedge Fund Activity: Q1 2019 in Review

356 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2019, worth a combined $7.07B — up 37% from $5.16B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TECH positions and 24 closed out — a net gain of 32 holders — while 128 added to existing stakes and 109 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $46.2M. The largest seller was AQR Capital Management, cutting an estimated $30.7M.

  • 356 institutional investors held Bio-Techne (TECH) as of Q1 2019, up from 328 in Q4 2018.
  • Funds reported $7.07B of Bio-Techne stock for Q1 2019, up 37% quarter-over-quarter.
  • 56 funds opened new Bio-Techne positions in Q1 2019 and 24 closed out, a net change of +32 holders.
  • The largest Bio-Techne buyer in Q1 2019 was Wellington Management Group, an estimated $46.2M added.
  • The largest Bio-Techne seller in Q1 2019 was AQR Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q1 2019.